Gap analysis and regulatory support in view of first in human (FIH) trial planned to be conducted in Europe

Case studies - 20 novembre 2018

BlueReg Group / Case studies / Gap analysis and regulatory support in view of first in human (FIH) trial planned to be conducted in Europe

Gap analysis and regulatory support in view of first in human (FIH) trial planned to be conducted in Europe

A US-based customer contacted BlueReg (BR) for assistance in reviewing the CMC and non-clinical development package in view of a FIH clinical trial that will be conducted in Europe.

Vous avez aimé cet article ? Partagez le sur les réseaux sociaux :

Download the
Case Study


BlueReg undertakes to comply with the regulations in force applicable to the processing of personal data and, in particular, Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 applicable as from 25 May 2018 (hereinafter, "the General Data Protection Regulations" or GPDR) and the national laws resulting therefrom.
Any inquiries, correction or declaration of event related to personal data processed should be sent to: our contact page
Learn more

Thank you for your reply

You can download the file below

Télécharger

Découvrez notre dernier livre blanc

En savoir plus